1. Home
  2. TCPC vs BNTC Comparison

TCPC vs BNTC Comparison

Compare TCPC & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock TCP Capital Corp.

TCPC

BlackRock TCP Capital Corp.

HOLD

Current Price

$3.85

Market Cap

407.2M

Sector

Finance

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$11.38

Market Cap

371.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCPC
BNTC
Founded
2006
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.2M
371.0M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
TCPC
BNTC
Price
$3.85
$11.38
Analyst Decision
Sell
Strong Buy
Analyst Count
2
3
Target Price
$3.50
$27.67
AVG Volume (30 Days)
1.2M
159.4K
Earning Date
06-01-2026
05-22-2026
Dividend Yield
20.15%
N/A
EPS Growth
N/A
80.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.83
$9.85
52 Week High
$8.36
$17.15

Technical Indicators

Market Signals
Indicator
TCPC
BNTC
Relative Strength Index (RSI) 24.35 51.96
Support Level N/A $11.30
Resistance Level $5.99 $12.75
Average True Range (ATR) 0.16 0.73
MACD -0.05 0.07
Stochastic Oscillator 1.30 90.34

Price Performance

Historical Comparison
TCPC
BNTC

About TCPC BlackRock TCP Capital Corp.

BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: